Ruifeng Chen

Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial

Assuntina G. Sacco, Ruifeng Chen, Francis P. Worden et al. · The Lancet Oncology · 2021 · 258 citations · Full text

Medicine, Oncology, Cancer Pharmacology +10

Effectiveness of e-cigarettes as aids for smoking cessation: evidence from the PATH Study cohort, 2017–2019

Ruifeng Chen, John P. Pierce, Eric C. Leas et al. · Tobacco Control · 2022 · 99 citations · Full text

Public Health, Preventive Medicine, Behavioral Epidemiology +16

Use of E-cigarettes and Other Tobacco Products and Progression to Daily Cigarette Smoking

John P. Pierce, Ruifeng Chen, Eric C. Leas et al. · PEDIATRICS · 2021 · 80 citations · Full text

Public Health, Population Health Sciences, Epidemiology +14

Role of e-cigarettes and pharmacotherapy during attempts to quit cigarette smoking: The PATH Study 2013-16

John P. Pierce, Tarik Benmarhnia, Ruifeng Chen et al. · PLoS ONE · 2020 · 73 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17

Use of Electronic Cigarettes to Aid Long-Term Smoking Cessation in the United States: Prospective Evidence From the PATH Cohort Study

Ruifeng Chen, John P. Pierce, Eric C. Leas et al. · American Journal of Epidemiology · 2020 · 55 citations · Full text

Public Health, Health Behavior, Population Health Sciences +17